With the development of the Intubation Surfactant Extubation technic, in which surfactant is administered during a brief intubation followed by immediate extubation, surfactant therapy can be given during nasal continuous positive airway pressure treatment further reducing need for mechanical ventilation. Preterm newborn babies until eight hours of life, with respiratory distress syndrome, will be randomized to standard delivery of surfactant via endotracheal tube airway inserted after premedication for pain with midazolam and remifentanil or to surfactant delivery via Proseal laryngeal mask airway size 1. The intent is to is to compare efficacy and safety of surfactant administration via two different airways and ventilatory approaches.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
60
Surfactant endotracheal administration after tracheal intubation
Surfactant use by proseal laryngeal mask airway
Maternidade Odete Valadares
Belo Horizonte, Minas Gerais, Brazil
Hospital Dia e Maternidade Unimed-BH
Belo Horizonte, Minas Gerais, Brazil
Fraction of inspired oxygen
Time frame: three hours
Hormonal evaluation of pain
Time frame: three hours
Proseal laryngeal mask surfactant treatment failure
Time frame: Six hours
Rate of respiratory distress syndrome complications
Time frame: 28 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.